Given its prominent role in adipogenesis, it is not surprising that increased expression of Pparγ/Rxr has been found in liposarcomas that were triggered to undergo terminal differentiation in vitro by thiazolidinediones or TZDs (class of antidiabetic drugs) and Rxr-specific retinoids (194). Here, PPARG is linked to liposarcoma.